63927-95-7

Basic information

• Product Name: Bentemazole
• Synonyms: Bentemazole;5-(1-Benzyl-1H-imidazol-2-yl)-1H-tetrazole
• CAS NO: 63927-95-7
• Molecular Formula: C₁₁H₁₀N₆
• Molecular Weight: 226.24
• Mol File: 63927-95-7.mol

Chemical Properties

• Boiling Point: 509.5°C at 760 mmHg
• Flash Point: 262°C
• Appearance: /
• Density: 1.42g/cm³
• Vapor Pressure: 1.68E-10mmHg at 25°C
• Refractive Index: 1.753
• CAS DataBase Reference: Bentemazole(CAS DataBase Reference)
• NIST Chemistry Reference: Bentemazole(63927-95-7)
• EPA Substance Registry System: Bentemazole(63927-95-7)

Safety Data

• Hazardous Substances Data: 63927-95-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H10N6/c1-2-4-9(5-3-1)8-17-7-6-12-11(17)10-13-15-16-14-10/h1-7H,8H2,(H,13,14,15,16)

Upstream product

• 46323-27-7 1-(Phenylmethyl)-1H-imidazole-2-carbonitrile 
• 10045-65-5 N-benzylimidazole-2-carboxaldehyde 
• 10045-64-4 1-benzylimidazole-2-carboxaldehyde oxime 

Relevant articles and documents

Novel derivatives of imidazole, and pharmaceutical compositions containing them

A compound of one of formulae (I) and (II) (of formula sheet) wherein R1 represents a radical selected from the group consisting of hydrogen alkyl containing up to 6 carbon atoms and being unsubstituted or substituted by at least one of the groups alkoxy and phenylalkoxy containing up to 4 carbon atoms in the alkoxy moiety; aryl or aralkyl each containing from 1 to 4 carbon atoms in the alkyl moiety and being unsubstituted or substituted by at least one substituent selected from the group consisting of alkyl, alkoxy and haloalkyl containing up to 4 carbon atoms, halogen and nitro; a 5- or 6-membered heteroaromatic ring containing up to 2 hetero atoms chosen from O,N and S, at most one of which is different from nitrogen; an alkyl group containing from 1 to 4 carbon atoms substituted by such a heteroaromatic ring; R2 and R3, which are the same or different, each represents a hydrogen atom or, alkyl containing up to 4 carbon atoms and being unsubstituted or substituted by at least one substituent selected from the group consisting of alkyl, alkoxy and haloalkyl containing up to 4 carbon atoms, halogen and nitro; taken together R2 and R3 alternatively represent a --CH=CH--CH=CH-- group which is unsubstituted or substituted by a substituent selected from the group consisting of alkyl, alkoxy and haloalkyl, each containing up to 4 carbon atoms, halogen and nitro; R4 is selected from the group consisting of hydrogen alkyl, aryl and aralkyl containing up to 4 carbon atoms in each alkyl moiety; and A represents a single bond or alkylene containing from 1 to 6 carbon atoms; with the proviso that R1 is other than a hydrogen atom or methyl group when A represents a single bond and R2 and R3 taken together represent an unsubstituted --CH=CH--CH=CH-- group; physiologically acceptable salts thereof, a synthesis therefor and a pharmaceutical composition containing it.